ES2530769T3 - Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno - Google Patents
Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno Download PDFInfo
- Publication number
- ES2530769T3 ES2530769T3 ES95923042T ES95923042T ES2530769T3 ES 2530769 T3 ES2530769 T3 ES 2530769T3 ES 95923042 T ES95923042 T ES 95923042T ES 95923042 T ES95923042 T ES 95923042T ES 2530769 T3 ES2530769 T3 ES 2530769T3
- Authority
- ES
- Spain
- Prior art keywords
- antigen
- cells
- vivo
- activation
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Uso de células dendríticas humanas aisladas que se han pulsado con un antígeno in vitro en la producción de un medicamento para activar una respuesta inmunitaria a un antígeno en un paciente humano.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25977494A | 1994-06-14 | 1994-06-14 | |
| PCT/US1995/007461 WO1995034638A1 (en) | 1994-06-14 | 1995-06-13 | Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2530769T3 true ES2530769T3 (es) | 2015-03-05 |
Family
ID=22986324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95923042T Expired - Lifetime ES2530769T3 (es) | 1994-06-14 | 1995-06-13 | Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0765386B1 (es) |
| JP (1) | JPH10504284A (es) |
| AU (1) | AU710783B2 (es) |
| CA (1) | CA2192655A1 (es) |
| DK (1) | DK0765386T3 (es) |
| ES (1) | ES2530769T3 (es) |
| PT (1) | PT765386E (es) |
| WO (1) | WO1995034638A1 (es) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT633929E (pt) * | 1992-04-01 | 2004-07-30 | Merix Bioscience Inc | Metodo para proliferacao (in vitro) de precursores de celulas dentifricas e sua utilizacao para produzir imunogenios |
| US6300090B1 (en) | 1994-07-29 | 2001-10-09 | The Rockefeller University | Methods of use of viral vectors to deliver antigen to dendritic cells |
| US5977316A (en) * | 1995-01-17 | 1999-11-02 | The Board Of Trustees Of The University Of Kentucky | Monoclonal antibody 1A7 and related polypeptides |
| US5935821A (en) * | 1995-01-17 | 1999-08-10 | Board Of Trustees Of The University Of Kentucky | Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| US5612030A (en) | 1995-01-17 | 1997-03-18 | University Of Kentucky Research Foundation | Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| US5788963A (en) * | 1995-07-31 | 1998-08-04 | Pacific Northwest Cancer Foundation | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| WO1997022349A1 (en) * | 1995-12-20 | 1997-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| US6080409A (en) * | 1995-12-28 | 2000-06-27 | Dendreon Corporation | Immunostimulatory method |
| US7659119B2 (en) | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
| CA2249412A1 (en) * | 1996-03-22 | 1997-09-25 | Yale University | Methods for inducing immune responsiveness in a subject |
| US5853719A (en) * | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| US7273753B2 (en) | 1996-08-02 | 2007-09-25 | Center Of Blood Research | Purification and uses of dendritic cells and monocytes |
| WO1998005795A1 (en) | 1996-08-02 | 1998-02-12 | The Center For Blood Research, Inc. | Enrichment of dendritic cells from blood |
| ATE229810T1 (de) * | 1996-10-11 | 2003-01-15 | Univ California | Krebs immuntherapie unter verwendung von tumorzellen kombiniert mit lymphozytmischungen |
| DE69839443D1 (de) | 1997-05-08 | 2008-06-19 | Biomira Inc | Verfahren zur gewinnung von aktivierten t-zellen und mit antigen inkubierten antigenpräsentierenden zellen |
| AU7499498A (en) | 1997-05-21 | 1998-12-11 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods and compositions for making dendritic cells from expanded populations ofmonocytes and for activating t cells |
| US6713250B1 (en) | 1997-08-08 | 2004-03-30 | The Research Foundation Of State University Of New York | Identification of human allergens and T-lymphocyte antigens in vitro |
| ATE428769T1 (de) | 1997-10-27 | 2009-05-15 | Univ Rockefeller | Methode und zusammensetzung zur herstellung von reifen dendritischen zellen |
| WO1999042564A2 (en) | 1998-02-20 | 1999-08-26 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
| FR2775692B1 (fr) * | 1998-03-03 | 2000-06-16 | Roussy Inst Gustave | Methodes d'activation de cellules tueuses naturelles (nk) et moyens de mise en oeuvre |
| US6849452B1 (en) * | 1998-03-03 | 2005-02-01 | Institut Gustave Roussy | Methods for activating natural killer (NK) cells and means for carrying out said methods |
| FR2782524B1 (fr) * | 1998-08-21 | 2002-07-19 | Roussy Inst Gustave | Methodes d'activation de cellules tueuses naturelles (nk) et moyens de mise en oeuvre |
| US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
| AU3456099A (en) | 1998-03-31 | 1999-10-18 | Geron Corporation | Methods and compositions for eliciting an immune response to a telomerase antigen |
| EP1082411A2 (en) * | 1998-06-02 | 2001-03-14 | Dendreon Corporation | Method for preparation and in vivo administration of antigen presenting cell composition |
| US7030211B1 (en) | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
| US20020142974A1 (en) * | 1998-09-11 | 2002-10-03 | Leonard D. Kohn | Immune activation by double-stranded polynucleotides |
| IT1312570B1 (it) * | 1999-05-28 | 2002-04-22 | Genera Spa | Metodo per il traferimento di antigeni a cellule dendritiche. |
| EP1237929A4 (en) * | 1999-12-03 | 2004-04-28 | Order Sisters Of Mercy Queensl | ANTIBODIES HAVING SPECIFICITY FOR DENDRITIC CELLS |
| AU2003231098A1 (en) | 2002-04-25 | 2003-11-10 | University Of Connecticut Health Center | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| US6984389B2 (en) * | 2002-04-25 | 2006-01-10 | University Of Connecticut Health Center | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| US8414899B2 (en) | 2006-04-11 | 2013-04-09 | Yeda Research And Development Co. Ltd. | Vaccines comprising multimeric HSP60 peptide carriers |
| WO2008055354A1 (en) * | 2006-11-10 | 2008-05-15 | Université de Montréal | Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods |
| DE102009017827A1 (de) * | 2009-04-20 | 2010-10-21 | Sasol Germany Gmbh | Verfahren zur Herstellung von verzweigten Kohlenwasserstoffen aus Fettalkoholen und Verwendung derartig hergestellter Kohlenwasserstoffe |
| BRPI0905536A2 (pt) * | 2009-12-16 | 2011-08-16 | Fundacao De Amparo A Pesquisa | processo de maturação de células dendrìticas autólogas |
| WO2012115276A1 (en) | 2011-02-23 | 2012-08-30 | Kyoto University | Method for producing dendritic cells from pluripotent stem cells |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030072751A1 (en) * | 1990-03-14 | 2003-04-17 | Heribert Bohlen | Idiotypic vaccination against b cell lymphoma |
| AU687733B2 (en) * | 1992-04-01 | 1998-03-05 | Rockefeller University, The | Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| WO1994002156A1 (en) * | 1992-07-16 | 1994-02-03 | The Board Of Trustees Of Leland Stanford Junior University | Methods for using dendritic cells to activate t cells |
-
1995
- 1995-06-13 DK DK95923042.6T patent/DK0765386T3/en active
- 1995-06-13 PT PT95923042T patent/PT765386E/pt unknown
- 1995-06-13 JP JP8502392A patent/JPH10504284A/ja not_active Ceased
- 1995-06-13 AU AU27725/95A patent/AU710783B2/en not_active Ceased
- 1995-06-13 ES ES95923042T patent/ES2530769T3/es not_active Expired - Lifetime
- 1995-06-13 WO PCT/US1995/007461 patent/WO1995034638A1/en not_active Ceased
- 1995-06-13 EP EP95923042.6A patent/EP0765386B1/en not_active Expired - Lifetime
- 1995-06-13 CA CA002192655A patent/CA2192655A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995034638A1 (en) | 1995-12-21 |
| AU710783B2 (en) | 1999-09-30 |
| PT765386E (pt) | 2015-02-06 |
| DK0765386T3 (en) | 2015-01-26 |
| AU2772595A (en) | 1996-01-05 |
| EP0765386A1 (en) | 1997-04-02 |
| JPH10504284A (ja) | 1998-04-28 |
| EP0765386B1 (en) | 2014-12-10 |
| CA2192655A1 (en) | 1995-12-21 |
| EP0765386A4 (en) | 1998-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2099211T3 (es) | Conjugados citomoduladores de miembros de parejas de union especifica. | |
| PT765386E (pt) | Processos para a activação in vivo de células t, através de células dendríticas pulsadas com antigénio | |
| ES2057124T3 (es) | Producto terapeutico para el tratamiento de estados peri- o post-menopausicos. | |
| ES2152483T3 (es) | Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b. | |
| EA199800946A1 (ru) | Концентрированный препарат антител | |
| GEP20022648B (en) | Method for Inducing T Cell Tolerance to a Tissue or Organ Graft | |
| BR9907189A (pt) | Produtos da fração lipìdica do carotenóide de pepino do mar e métodos de uso | |
| NO331101B1 (no) | In vitro-fremgangsmate for a uttrykke et antigenmolekyl og antigenmolekyl og et fotosensibiliserende middel for anvendelse ved uttrykking av antigenmolekylet. | |
| ES2053815T3 (es) | Preparacion farmaceutica con liberacion prolongada de una dihidropiridina y un antagonista de un beta-adrenorreceptor y un procedimiento para su preparacion. | |
| ES2142829T3 (es) | Dispositivos para llevar a cabo un procedimiento intraluminal. | |
| ES2112860T3 (es) | Inmunoterapia adoptiva con interleukina-7. | |
| ATE353363T1 (de) | Immunstimulierende zusammensetzung und verfahren | |
| IL161832A0 (en) | Pharmaceutical composition for inducing an immune response in a human or animal | |
| ES2060310T3 (es) | Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion. | |
| ES2170259T3 (es) | Empleo de lipidos como agentes auxiliares en la obtencion de formas farmaceuticas solidas segun el procedimiento de extrusion en fusion. | |
| AR004545A1 (es) | Derivados de purin-6-ona, procedimientos para su preparacion, el uso de los mismos en la preparacion de medicamentos, medicamentos que los contieneny un procedimiento para preparar dichos medicamentos | |
| ES8900007A1 (es) | Un metodo para producir normas orales frente a virus de hepatitis-b. | |
| SE9003718D0 (sv) | Implantat med genomgaaende passage | |
| PT1131408E (pt) | Acidos oligossacarido-aldonicos e sua utilizacao topica | |
| ATE422893T1 (de) | Mannose-rezeptor tragende zellinie und antigen zusammensetzung | |
| BG101401A (bg) | Състави за орално приложение с удължено освобождаване на цисаприд | |
| CY1104971T1 (el) | Παρασκευασμα αποϊνιδοτιδιου και g-csf και η χρηση του για να κινητοποιει αιμοποιητικους προγονους | |
| IL114458A0 (en) | Therapeutic preparations for treatment of T cell mediated diseases | |
| NZ507829A (en) | Vaccine adjuvants for immunotherapy of melanoma | |
| DK0391185T3 (da) | 1,8-Naphthyridiner |